ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G ...

'Exosomes,' biological particles responsible for signaling between cells, are gaining attention as a next-generation technology for treating intractable diseases due to their ability to deliver drugs ...

--Findings support the versatility of Capricor’s exosome technology, enabling efficient and scalable loading of siRNAs and PMOs to support future clinical development-- SAN DIEGO, Nov. 24, 2025 (GLOBE ...

Exosomes, naturally derived vesicles responsible for intercellular communication, are emerging as next-generation drug delivery systems capable of transporting therapeutics to specific cells. However, ...

The MarketWatch News Department was not involved in the creation of this content. --Findings support the versatility of Capricor's exosome technology, enabling efficient and scalable loading of siRNAs ...

--Findings support the versatility of Capricor’s exosome technology, enabling efficient and scalable loading of siRNAs and PMOs to support future clinical development-- The poster titled, “A ...